Not applicableUnknownNCT02854228What this trial is testingPITUItary Carcinoma or Aggressive Tumors REgistry -LyonWho this might be right forPituitary Tumor Hospices Civils de Lyon 1,300
Large-scale testing (Phase 3)Study completedNCT00936741What this trial is testingAn Extension Study of CORLUX in the Treatment of Endogenous Cushing's SyndromeWho this might be right forCushing's Syndrome Corcept Therapeutics 30
Large-scale testing (Phase 3)Study completedNCT00569582What this trial is testingThe Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's SyndromeWho this might be right forCushing's Syndrome Corcept Therapeutics 50
Not applicableNot Yet RecruitingNCT07695844What this trial is testingTemozolomide in Aggressive Pituitary Neuroendocrine Tumors: A Latin American Multicenter Retrospective Cohort (TMZ-LATAM)Who this might be right forPituitary Neoplasms University of Sao Paulo General Hospital 80
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)UnknownNCT01849484What this trial is testingEnhancement of Neurocognitive Functions by Hippocampal Sparing RadiotherapyWho this might be right forRadiation of Neurocranial Region University of Erlangen-Nürnberg Medical School 150
Testing effectiveness (Phase 2)WithdrawnNCT04106843What this trial is testingRadioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine CancersWho this might be right forLocally Advanced Adrenal Gland PheochromocytomaLocally Advanced ParagangliomaMetastatic Adrenal Gland Pheochromocytoma+11 more M.D. Anderson Cancer Center
Not applicableActive Not RecruitingNCT03583528What this trial is testingDOTATOC PET/CT for Imaging NET PatientsWho this might be right forNeuroendocrine TumorsInsulinomaGastrinoma+13 more British Columbia Cancer Agency 800
Not applicableLooking for participantsNCT06973824What this trial is testingA Twenty-years' Experience in Pituitary Disease.Who this might be right forPituitary AdenomaPituitary CancerPituitary Disease Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,600
Early research (Phase 1)Study completedNCT00446082What this trial is testingStudy of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid DiseaseWho this might be right forCarcinoid TumorAcromegaly Novartis Pharmaceuticals 85
Testing effectiveness (Phase 2)WithdrawnNCT00003514What this trial is testingAntineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation TherapyWho this might be right forMerkel Cell CarcinomaIslet Cell CarcinomaNeuroendocrine Carcinoma+1 more Burzynski Research Institute
Not applicableEnded earlyNCT00796783What this trial is testingConfirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of HypercortisolemiaWho this might be right forCushing's Syndrome Corcept Therapeutics 2
Testing effectiveness (Phase 2)Study completedNCT02804750What this trial is testingStudy to Evaluate CORT125134 in Participants With Cushing's SyndromeWho this might be right forCushing's Syndrome Corcept Therapeutics 35
Testing effectiveness (Phase 2)Study completedNCT04042753What this trial is testingNivolumab and Ipilimumab in People With Aggressive Pituitary TumorsWho this might be right forPituitaryPituitary TumorPituitary Carcinoma+1 more Memorial Sloan Kettering Cancer Center 10
Not applicableLooking for participantsNCT06523582What this trial is testingGenetic Bases of Neuroendocrine Neoplasms in Mexican PatientsWho this might be right forNeuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of Lung+23 more Universidad Nacional Autonoma de Mexico 750
Not applicableLooking for participantsNCT03382158What this trial is testingInternational PPB/DICER1 RegistryWho this might be right forPleuropulmonary BlastomaSertoli-Leydig Cell TumorDICER1 Syndrome+16 more Children's Hospitals and Clinics of Minnesota 3,400
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Active Not RecruitingNCT03604198What this trial is testingExtension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing SyndromeWho this might be right forCushing Syndrome Corcept Therapeutics 125
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Early research (Phase 1)Ended earlyNCT00002947What this trial is testingIndium In 111 Pentetreotide in Treating Patients With Refractory CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more Yale University 35